IL-6 hypothesis looking shaky as Kevzara fails COVID-19 trialHopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results Share XIL-6 hypothesis looking shaky as Kevzara fails COVID-19 trialhttps://pharmaphorum.com/news/il-6-hypothesis-looking-shaky-as-kevzara-fails-covid-19-trial/
FDA backs second rare disease drug from Ultragenyx in the space of a fortnightThe FDA has approved a second rare disease drug from California-based Ultragenyx in the space of a fortnight, for treatment Share XFDA backs second rare disease drug from Ultragenyx in the space of a fortnighthttps://pharmaphorum.com/news/fda-backs-ultragenyxs-second-rare-disease-drug-in-the-space-of-a-fortnight/
J&J’s Ebola vaccine approved in EUThe European Commission has approved Johnson & Johnson’s Ebola vaccine, developed by its Janssen pharmaceuticals unit and Bavarian Share XJ&J’s Ebola vaccine approved in EUhttps://pharmaphorum.com/news/jjs-ebola-vaccine-approved-in-eu/
Payments from UK pharma to healthcare professionals increased in 2019The UK’s pharmaceutical industry has published headline figures from its Disclosure UK scheme, showing payments from pharma to Share XPayments from UK pharma to healthcare professionals increased in 2019https://pharmaphorum.com/news/payments-from-uk-pharma-to-healthcare-professionals-increased-in-2019/
AI health record scanning could identify pancreatic cancer earlyArtificial intelligence (AI) could hold the key to identifying people at risk of pancreatic cancer early, allowing them Share XAI health record scanning could identify pancreatic cancer earlyhttps://pharmaphorum.com/news/ai-health-record-scanning-could-identify-pancreatic-cancer-early/
Healthcare communications body the HCA appoints new boardPictured above, clockwise from top left: Jo Tayler, Emma Kenny, Edel McCaffrey, Annabelle Sandeman, Alice Choi and Alister Share XHealthcare communications body the HCA appoints new boardhttps://pharmaphorum.com/news/healthcare-communications-hca-board/
Survey shows patients wait six times longer than EU neighbours for new drugsPatients in some European countries are waiting up to six times longer for access to medicines than their neighbours, Share XSurvey shows patients wait six times longer than EU neighbours for new drugshttps://pharmaphorum.com/news/survey-shows-patients-wait-six-times-longer-than-eu-neighbours-for-new-drugs/
Amgen wins latest round in legal tussle over Enbrel patentsAmgen’s reputation as a fearsome adversary in the courtroom remains intact after it won the latest round in Share XAmgen wins latest round in legal tussle over Enbrel patentshttps://pharmaphorum.com/news/amgen-wins-latest-round-in-legal-tussle-over-enbrel-patents/
Novartis pays $678 million to settle US kickback allegationsAnother nail has been hammered into the coffin of the pharma model of providing lavish entertainment and other Share XNovartis pays $678 million to settle US kickback allegationshttps://pharmaphorum.com/news/novartis-pays-678-million-to-settle-us-kickback-allegations/
